Alessia Potenza
5PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 14, 2026
T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradication.Francesca Marzuttini, Alessia Potenza, Ludovica Celli
|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.Martina Spiga, Alessia Potenza, Zulma Magnani
|Dec 01, 2023
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.Francesco Manfredi, Lorena Stasi, Silvia Buonanno
|Jul 03, 2023
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.Alessia Potenza, Chiara Balestrieri, Martina Spiga
|Feb 09, 2022
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.Eliana Ruggiero, Erica Carnevale, Aaron Prodeus
Pageof 1
Frequent Collaborators
4 joint publications
Eliana Ruggiero
3 joint publications
Chiara Bonini
3 joint publications
Danilo Abbati
3 joint publications
Luca Vago
3 joint publications
Francesca Sanvito
2 joint publications
Zulma Magnani
2 joint publications
Lorena Stasi
2 joint publications
Beatrice Claudia Cianciotti
2 joint publications
Francesco Manfredi
2 joint publications
Fabio Ciceri
